Skip to content
Search

Latest Stories

Final Report: Cass review suggests 32 recommendations for children's gender care

Final Report: Cass review suggests 32 recommendations for children's gender care
The review highlights "unclear" evidence supporting the "impact of Puberty Suppressing Hormones on cognitive and psychosexual development" as part of  children's gender care

A final review of gender services provided by the NHS has uncovered significant shortcomings, leaving thousands of vulnerable children questioning their gender identity without adequate support.

The report, led by Dr. Hilary Cass, a prominent consultant paediatrician, highlights the use of unproven treatments and the detrimental impact of the polarized trans debate on gender care provision.


The investigation, commissioned by NHS England in 2020, focused on the Tavistock and Portman NHS mental health trust’s gender identity development services (Gids), which treated around 9,000 children and young people between 2009 and 2020.

Shockingly, the review found that despite limited evidence of effectiveness and potential health risks, puberty blockers and cross-sex hormones were routinely administered.

Dr. Cass emphasized that the "rationale for early puberty suppression remains unclear, with weak evidence regarding the impact on gender dysphoria, mental or psychosocial health. The effect on cognitive and psychosexual development remains unknown."

She highlighted the toxic nature of the public discourse surrounding gender issues, which has hindered open discussion and led to the misrepresentation of research findings.

In response to the report's findings, NHS England has taken decisive action, closing Gids and adopting a "holistic" approach to care.

Under the new model, psychological support will take precedence over medical intervention for under-18s grappling with gender identity issues.

The emphasis is on personalized care plans, including thorough assessments for neurodevelopmental conditions like ADHD, autism, and other mental health conditions.

The report also called for caution in the "use of masculinizing/feminizing hormones", particularly for individuals under 18, stressing the need for clear clinical justifications for such treatments.

It also highlighted the need for "provision for people considering detransition, recognising that they may not wish to re-engage with the services whose care they were previously under."

A spokesperson for the NHSE said, "the NHS is bringing forward its systemic review of adult gender services and has written to local NHS leaders to ask them to pause offering first appointments at adult gender clinics to young people below their 18th birthday.”

In conclusion, the report signals a pivotal moment for NHS gender services, recommending up to 32 suggestions to shift to evidence-based care for children dealing with gender dysphoria.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less